RB
Rakesh Bamzai
About Rakesh Bamzai
Data last updated:
Rakesh Bamzai was a Ceo at Intas Pharmaceuticals Limited (2024–2025), Managing Director at Mylan Laboratories Limited (2014–2024) and Additional Director at Jai Pharma Limited (from 2015). The companies operate in Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Intas Pharmaceuticals Limited U24231GJ1985PLC007866 | Ceo | 19 Sep 2024 | 1985 | ₹21,241 Cr (FY 2025) | Active |
 Mylan Laboratories Limited U24231TG1984PLC005146 | Managing Director | 01 Nov 2014 | 1984 | ₹7,504 Cr (FY 2025) | Active |
 Jai Pharma Limited U74999MH2015PLC262055 | Additional Director | 20 Nov 2015 | 2015 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rakesh Bamzai
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rakesh Bamzai
Rakesh Bamzai was first appointed on 01 Nov 2014 as Managing Director at Mylan Laboratories Limited. The most recent appointment on record is 19 Sep 2024 at Intas Pharmaceuticals Limited.
Rakesh Bamzai held 3 earlier board appointments: Intas Pharmaceuticals Limited (Ceo, 19 Sep 2024 to 01 Dec 2025); Mylan Laboratories Limited (Managing Director, 01 Nov 2014 to 31 Mar 2024); Jai Pharma Limited (Additional Director, from 20 Nov 2015).